Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192163 · ClinicalTrials.gov registry record
Cultural Differences in Treatment Preferences and Perceptions of Acne
A clinical trial of Acne Vulgaris, sponsored by Northwestern University.
- Completed
- Registry status
- 217
- Enrollment target
- 1
- Study location
NCT03192163 is a study of Acne Vulgaris that has completed, run by Northwestern University. The registered enrollment target is 217 participants, below the 272-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03192163, a study of Acne Vulgaris, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use a survey to examine relationships between culture, race, and ethnicity with treatment preferences and perceptions for acne vulgaris.
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03192163
The ClinicalTrials.gov registry entry for NCT03192163 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (20% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03192163 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03192163 about?
NCT03192163 is a clinical study titled "Cultural Differences in Treatment Preferences and Perceptions of Acne". This study will use a survey to examine relationships between culture, race, and ethnicity with treatment preferences and perceptions for acne vulgaris.
What is the current status of trial NCT03192163?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2015-06. Estimated completion is 2018-02.
What conditions does trial NCT03192163 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT03192163?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03192163?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03192163 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Weekly Isotretinoin vs Tetracycline for Moderate Acne
RECRUITING · Early Phase 1
-
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
RECRUITING · Phase 1
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
ACTIVE NOT RECRUITING · Phase 4
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.